Literature DB >> 6122111

Treatment of refractory hypertension.

J D Swales, R F Bing, A Heagerty, J E Pohl, G I Russell, H Thurston.   

Abstract

126 patients with blood pressure which was unacceptably high despite a conventional stepped-care regimen (diuretic, beta-blocker, and vasodilator) took part in a comparative assessment of different approaches to the treatment of refractory hypertension. One of four regimens was used: oral diazoxide, minoxidil, captopril, or quadruple therapy (diuretic + beta-adrenoceptor blocker + hydralazine + prazosin). Despite the severity of hypertension, blood pressure could be controlled in almost all these patients, and no patient died from cerebrovascular disease while on treatment. 2 patients died of renal failure and 5 patients required long-term haemodialysis. Ischaemic heart disease remained a problem and caused the death of 10 patients. Diazoxide was the most effective treatment but was the most difficult and unpleasant to use. Captopril was the best-tolerated but failed to control blood pressure in 6 of 15 patients. Our experience indicates that there are now sufficient therapeutic alternatives to achieve acceptable blood-pressure control in almost all patients with "refractory" hypertension, although no treatment is ideal.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6122111     DOI: 10.1016/s0140-6736(82)92162-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

Review 1.  Treatment of resistant hypertension.

Authors:  Sandra J Taler
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

2.  [Resistant hypertension : What is it?].

Authors:  F C Luft
Journal:  Internist (Berl)       Date:  2015-03       Impact factor: 0.743

3.  Predictors of resistant hypertension in an unselected sample of an adult male population in Italy.

Authors:  Antonio Barbato; Ferruccio Galletti; Roberto Iacone; Francesco P Cappuccio; Giovanni Rossi; Renato Ippolito; Antonella Venezia; Eduardo Farinaro; Pasquale Strazzullo
Journal:  Intern Emerg Med       Date:  2011-03-10       Impact factor: 3.397

4.  Effects of treatment for hypertension on cerebral haemorrhage and infarction.

Authors:  D G Black; A M Heagerty; R F Bing; H Thurston; J D Swales
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-21

5.  "Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.

Authors:  D McAreavey; L E Ramsey; L Latham; A D McLaren; A R Lorimer; J L Reid; J I Robertson; M P Robertson; R J Weir
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-14

Review 6.  Diabetes and arterial hypertension.

Authors:  P L Drury
Journal:  Diabetologia       Date:  1983-01       Impact factor: 10.122

Review 7.  Treatment resistant hypertension--investigation and conservative management.

Authors:  Franz Weber; Manfred Anlauf
Journal:  Dtsch Arztebl Int       Date:  2014-06-20       Impact factor: 5.594

Review 8.  Direct-acting vasodilators.

Authors:  Jay N Cohn; Gordon T McInnes; Alexander M Shepherd
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-07-18       Impact factor: 3.738

9.  Minoxidil for Treatment of Resistant Hypertension in Chronic Kidney Disease--A Retrospective Cohort Analysis.

Authors:  Heiko M Mundt; Matthias Matenaer; Alexander Lammert; Uwe Göttmann; Bernhard K Krämer; Rainer Birck; Urs Benck
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-01       Impact factor: 3.738

10.  Three in one: safety, efficacy, and patient acceptability of triple fixed-dose combination medicine in the management of hypertension.

Authors:  Addison A Taylor; Shawn Ragbir
Journal:  Patient Prefer Adherence       Date:  2012-08-01       Impact factor: 2.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.